fbpx

Hvem er vi

Lundbeckfonden Emerge is led by Christian E. Elling who works closely with the team of Lundbeckfonden Ventures and Lundbeckfonden as well as outside resources complementing the skillset of Lundbeckfonden Emerge.

Lundbeckfonden Emerge

Christian Elling

Christian Elling

Managing Partner
Paul Little

Paul Little

Operating Partner
Jette Brandsen Bundgaard

Jette Brandsen Bundgaard

PA / Office Manager

Engebret Lønnum

Student Assistant

Lundbeckfonden Emerge

Nyheder

IO Biotech Completes Oversubscribed EUR 127 Million Series B Financing to Accelerate Clinical Programs in Oncology
13. januar 2021
Lundbeckfonden øger sit engagement i IO Biotech
12. januar 2021
The Food and Drug Administration (FDA) grants IO Biotech breakthrough therapy designation for IO102 and IO103 in combination with anti-PD-1 in unresectable/ metastatic melanoma
15. december 2020